IMMX icon

Immix Biopharma

16 hedge funds and large institutions have $1.39M invested in Immix Biopharma in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 0 reducing their positions, and 5 closing their positions.

Holders
16
Holders Change
-2
Holders Change %
-11.11%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
8
Reduced
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$363K 106,210 +853 +0.8%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$250K 73,022 +12,696 +21%
Koshinski Asset Management
3
Koshinski Asset Management
Illinois
$174K 51,001
State Street
4
State Street
Massachusetts
$147K 42,960
Commonwealth Equity Services
5
Commonwealth Equity Services
Massachusetts
$99K 28,855 +6,030 +26%
IW
6
Imprint Wealth
South Carolina
$78.9K 23,083 +803 +4%
MAWA
7
Moss Adams Wealth Advisors
Washington
$68.4K 20,000
BlackRock
8
BlackRock
New York
$61.5K 17,991 +2,343 +15%
ICG
9
InterOcean Capital Group
Tennessee
$54.4K 15,900
TAM
10
Tocqueville Asset Management
New York
$41K 12,000 +12,000 New
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$40.7K 11,915 +4 +0%
TIM
12
Tortoise Investment Management
New York
$4.45K 1,300 +300 +30%
Morgan Stanley
13
Morgan Stanley
New York
$1.37K 400 +400 New
Osaic Holdings
14
Osaic Holdings
Arizona
$1.2K 350
Wells Fargo
15
Wells Fargo
California
$195 57 +15 +36%
JPMorgan Chase & Co
16
JPMorgan Chase & Co
New York
$24 7 +7 New
LCM
17
Lynwood Capital Management
Ontario, Canada
-200,250 Closed
UB
18
UMB Bank
Missouri
-72,639 Closed
Renaissance Technologies
19
Renaissance Technologies
New York
-10,600 Closed
PA
20
Parallel Advisors
California
-2,890 Closed
TRCT
21
Tower Research Capital (TRC)
New York
-120 Closed
CFGS
22
Concourse Financial Group Securities
Alabama